|
1
|
Seligson DB, Horvath S, McBrian MA, Mah V,
Yu H, Tze S, Wang Q, Chia D, Goodglick L and Kurdistani SK: Global
levels of histone modifications predict prognosis in different
cancers. Am J Pathol. 174:1619–1628. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lim S, Metzger E, Schüle R, Kirfel J and
Buettner R: Epigenetic regulation of cancer growth by histone
demethylases. Int J Cancer. 127:1991–1998. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hayami S, Kelly JD, Cho HS, Yoshimatsu M,
Unoki M, Tsunoda T, Field HI, Neal DE, Yamaue H, Ponder BA, et al:
Overexpression of LSD1 contributes to human carcinogenesis through
chromatin regulation in various cancers. Int J Cancer. 128:574–586.
2011. View Article : Google Scholar
|
|
4
|
Kahl P, Gullotti L, Heukamp LC, Wolf S,
Friedrichs N, Vorreuther R, Solleder G, Bastian PJ, Ellinger J,
Metzger E, et al: Androgen receptor coactivators lysine-specific
histone demethylase 1 and four and a half LIM domain protein 2
predict risk of prostate cancer recurrence. Cancer Res.
66:11341–11347. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lim S, Janzer A, Becker A, Zimmer A,
Schüle R, Buettner R and Kirfel J: Lysine-specific demethylase 1
(LSD1) is highly expressed in ER-negative breast cancers and a
biomarker predicting aggressive biology. Carcinogenesis.
31:512–520. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schulte JH, Lim S, Schramm A, Friedrichs
N, Koster J, Versteeg R, Ora I, Pajtler K, Klein-Hitpass L,
Kuhfittig-Kulle S, et al: Lysine-specific demethylase 1 is strongly
expressed in poorly differentiated neuroblastoma: implications for
therapy. Cancer Res. 69:2065–2071. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Singh MM, Manton CA, Bhat KP, Tsai WW,
Aldape K, Barton MC and Chandra J: Inhibition of LSD1 sensitizes
glioblastoma cells to histone deacetylase inhibitors. Neuro-oncol.
13:894–903. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schenk T, Chen WC, Göllner S, Howell L,
Jin L, Hebestreit K, Klein HU, Popescu AC, Burnett A, Mills K, et
al: Inhibition of the LSD1 (KDM1A) demethylase reactivates the
all-trans-retinoic acid differentiation pathway in acute myeloid
leukemia. Nat Med. 18:605–611. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Culhane JC and Cole PA: LSD1 and the
chemistry of histone demethylation. Curr Opin Chem Biol.
11:561–568. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rotili D and Mai A: Targeting histone
demethylases: a new avenue for the fight against cancer. Genes
Cancer. 2:663–679. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pui CH, Relling MV and Downing JR: Acute
lymphoblastic leukemia. N Engl J Med. 350:1535–1548. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li Y, Deng C, Hu X, Patel B, Fu X, Qiu Y,
Brand M, Zhao K and Huang S: Dynamic interaction between TAL1
oncoprotein and LSD1 regulates TAL1 function in hematopoiesis and
leukemogenesis. Oncogene. 31:5007–5018. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Alinari L, Christian B and Baiocchi RA:
Novel targeted therapies for mantle cell lymphoma. Oncotarget.
3:203–211. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Marks DI and Rowntree C: Management of
adults with T-cell lymphoblastic leukemia. Blood. 129:1134–1142.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Forneris F, Binda C, Vanoni MA, Mattevi A
and Battaglioli E: Histone demethylation catalysed by LSD1 is a
flavin-dependent oxidative process. FEBS Lett. 579:2203–2207. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shi Y and Whetstine JR: Dynamic regulation
of histone lysine methylation by demethylases. Mol Cell. 25:1–14.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang M, Culhane JC, Szewczuk LM, Gocke CB,
Brautigam CA, Tomchick DR, Machius M, Cole PA and Yu H: Structural
basis of histone demethylation by LSD1 revealed by suicide
inactivation. Nat Struct Mol Biol. 14:535–539. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee MG, Wynder C, Cooch N and Shiekhattar
R: An essential role for CoREST in nucleosomal histone 3 lysine 4
demethylation. Nature. 437:432–435. 2005.PubMed/NCBI
|
|
19
|
Gatta R and Mantovani R: NF-Y substitutes
H2A-H2B on active cell-cycle promoters: recruitment of CoREST-KDM1
and fine-tuning of H3 methylations. Nucleic Acids Res.
36:6592–6607. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lv T, Yuan D, Miao X, Lv Y, Zhan P, Shen X
and Song Y: Over-expression of LSD1 promotes proliferation,
migration and invasion in non-small cell lung cancer. PLoS One.
7:e350652012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wei SH, Balch C, Paik HH, Kim YS, Baldwin
RL, Liyanarachchi S, Li L, Wang Z, Wan JC, Davuluri RV, et al:
Prognostic DNA methylation biomarkers in ovarian cancer. Clin
Cancer Res. 12:2788–2794. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tsai HC and Baylin SB: Cancer epigenetics:
linking basic biology to clinical medicine. Cell Res. 21:502–517.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Suikki HE, Kujala PM, Tammela TL, van
Weerden WM, Vessella RL and Visakorpi T: Genetic alterations and
changes in expression of histone demethylases in prostate cancer.
Prostate. 70:889–898. 2010.PubMed/NCBI
|
|
24
|
Balch C, Fang F, Matei DE, Huang TH and
Nephew KP: Minireview: epigenetic changes in ovarian cancer.
Endocrinology. 150:4003–4011. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Asadollahi R, Hyde CA and Zhong XY:
Epigenetics of ovarian cancer: from the lab to the clinic. Gynecol
Oncol. 118:81–87. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Su H, Ma X, Huang Y, Han H, Zou Y and
Huang W: JARID1B deletion induced apoptosis in JeKo-1 and HL-60
cell lines. Int J Clin Exp Pathol. 8:171–183. 2015.PubMed/NCBI
|
|
27
|
Zou Y, Ma X, Huang Y, Hong L and Chiao JW:
Effect of phenylhexyl isothiocyanate on aberrant histone H3
methylation in primary human acute leukemia. J Hematol Oncol.
5:36–42. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Willmann D, Lim S, Wetzel S, Metzger E,
Jandausch A, Wilk W, Jung M, Forne I, Imhof A, Janzer A, et al:
Impairment of prostate cancer cell growth by a selective and
reversible lysine-specific demethylase 1 inhibitor. Int J Cancer.
131:2704–2709. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jin L, Hanigan CL, Wu Y, Wang W, Park BH,
Woster PM and Casero RA Jr: Loss of Lysine-Specific Demethylase 1
(LSD1)suppresses growth and alters gene expression of human colon
cancer cells in a p53 and DNA methyltransferase 1
(DNMT1)independent manner. Biochem J. 449:459–468. 2013. View Article : Google Scholar
|
|
30
|
Zhao ZK, Dong P, Gu J, Chen L, Zhuang M,
Lu WJ, Wang DR and Liu YB: Overexpression of LSD1 in hepatocellular
carcinoma: a latent target for the diagnosis and therapy of
hepatoma. Tumour Biol. 34:173–180. 2013. View Article : Google Scholar
|
|
31
|
Cho HS, Suzuki T, Dohmae N, Hayami S,
Unoki M, Yoshimatsu M, Toyokawa G, Takawa M, Chen T, Kurash JK, et
al: Demethylation of RB regulator MYPT1 by histone demethylase LSD1
promotes cell cycle progression in cancer cells. Cancer Res.
71:655–660. 2011. View Article : Google Scholar
|
|
32
|
Ding J, Zhang ZM, Xia Y, Liao GQ, Pan Y,
Liu S, Zhang Y and Yan ZS: LSD1-mediated epigenetic modification
contributes to proliferation and metastasis of colon cancer. Br J
Cancer. 109:994–1003. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Scoumanne A and Chen X: The
lysine-specific demethylase 1 is required for cell proliferation in
both p53-dependent and -independent manners. J Biol Chem.
282:15471–15475. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bodoor K, Haddad Y, Alkhateeb A, Al-Abbadi
A, Dowairi M, Magableh A, Bsoul N, Ghabkari A and Bodoor K: DNA
hypermethylation of cell cycle (p15 and p16) and apoptotic (p14,
p53DAPK and TMS1) genes in peripheral blood of leukemia patients.
Asian Pac J Cancer Prev. 15:75–84. 2014. View Article : Google Scholar
|
|
35
|
Wang J, Hevi S, Kurash JK, Lei H, Gay F,
Bajko J, Su H, Sun W, Chang H, Xu G, et al: The lysine demethylase
LSD1 (KDM1) is required for maintenance of global DNA methylation.
Nat Genet. 41:125–129. 2009. View
Article : Google Scholar
|
|
36
|
Wen L, Chen Y, Zeng LL, Zhao F, Li R, Liu
Y and Zhang C: Triptolide induces cell-cycle arrest and apoptosis
of human multiple myeloma cells in vitro via altering expression of
histone demethylase LSD1 and JMJD2B. Acta Pharmacol Sin.
33:109–119. 2012. View Article : Google Scholar
|
|
37
|
Sabattini E, Bacci F, Sagramoso C and
Pileri SA: WHO classification of tumours of haematopoietic and
lymphoid tissues in2008: an overview. Pathologica. 102:83–87.
2010.PubMed/NCBI
|
|
38
|
Kitazawa S, Kitazawa R and Maeda S:
Transcriptional regulation of rat cyclin D1 gene by CpG methylation
status in promoter region. J Biol Chem. 274:28787–28793. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shi Y, Lan F, Matson C, Mulligan P,
Whetstine JR, Cole PA, Casero RA and Shi Y: Histone demethylation
mediated by the nuclear amine oxidase homolog LSD1. Cell.
119:941–953. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shi YJ, Matson C, Lan F, Iwase S, Baba T
and Shi Y: Regulation of LSD1 histone demethylase activity by its
associated factors. Mol Cell. 19:857–864. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lan F, Collins RE, De Cegli R, Alpatov R,
Horton JR, Shi X, Gozani O, Cheng X and Shi Y: Recognition of
unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene
repression. Nature. 448:718–722. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gore SD, Baylin S, Sugar E, Carraway H,
Miller CB, Carducci M, Grever M, Galm O, Dauses T, Karp JE, et al:
Combined DNA methyltransferase and histone deacetylase inhibition
in the treatment of myeloid neoplasms. Cancer Res. 66:6361–6369.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Huang Y, Vasilatos SN, Boric L, Shaw PG
and Davidson NE: Inhibitors of histone demethylation and histone
deacetylation cooperate in regulating gene expression and
inhibiting growth in human breast cancer cells. Breast Cancer Res
Treat. 131:777–789. 2012. View Article : Google Scholar
|
